Literature DB >> 197411

Phenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line.

C Rosenfeld, A Goutner, C Choquet, A M Venuat, B Kayibanda, J L Pico, M F Greaves.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 197411     DOI： 10.1038/267841a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  50 in total

1.  Plateau distributions of DNA fragment lengths produced by extended light exposure of extranuclear photosensitizers in human cells.

Authors:  E Kvam; T Stokke; J Moan; H B Steen
Journal:  Nucleic Acids Res       Date:  1992-12-25       Impact factor: 16.971

2.  Use of stimulating capacity of mixed lymphocyte reaction (MLR-S) as a possible marker for the cell-origin of null-cell acute lymphoblastic leukaemia.

Authors:  T Han; J Minowada
Journal:  Immunology       Date:  1978-08       Impact factor: 7.397

3.  Cell cycle-specific expression and nuclear binding of DNA polymerase alpha.

Authors:  T Stokke; B Erikstein; H Holte; S Funderud; H B Steen
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

4.  cAMP-mediated inhibition of DNA replication and S phase progression: involvement of Rb, p21Cip1, and PCNA.

Authors:  Soheil Naderi; Jean Y J Wang; Tung-Ti Chen; Kristine B Gutzkow; Heidi K Blomhoff
Journal:  Mol Biol Cell       Date:  2005-01-12       Impact factor: 4.138

5.  Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia.

Authors:  Matthew G Guenther; Lee N Lawton; Tatiana Rozovskaia; Garrett M Frampton; Stuart S Levine; Thomas L Volkert; Carlo M Croce; Tatsuya Nakamura; Eli Canaani; Richard A Young
Journal:  Genes Dev       Date:  2008-12-15       Impact factor: 11.361

Review 6.  Genetics of neoplasia--impact of ecogenetics on oncogenesis. A review.

Authors:  D T Purtilo; L Paquin; T Gindhart
Journal:  Am J Pathol       Date:  1978-06       Impact factor: 4.307

7.  Monoclonal antibody directed to a B-cell antigen present in rats, mice, and humans.

Authors:  D L Gasser; B A Winters; J B Haas; T J McKearn; R H Kennett
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

8.  BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.

Authors:  Christopher J Ott; Nadja Kopp; Liat Bird; Ronald M Paranal; Jun Qi; Teresa Bowman; Scott J Rodig; Andrew L Kung; James E Bradner; David M Weinstock
Journal:  Blood       Date:  2012-08-17       Impact factor: 22.113

9.  Appearance of B- or T-lymphocyte markers after diffusion chamber culture of acute lymphoblastic leukemia cells.

Authors:  E Thiel; B Lau; H Rodt; G Jäger; K Pachmann
Journal:  Blut       Date:  1981-05

10.  A study of the mechanisms of cytotoxicity of Ara-C on three human leukemic cell lines.

Authors:  J Zittoun; J Marquet; J C David; D Maniey; R Zittoun
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.